Heart News and Research

RSS

Autistic people report worse menopause symptoms and lower quality of life

A new study by researchers at Bournemouth University has shown that autistic people consistently experience more severe menopausal symptoms than non-autistic people, leading to poorer wellbeing and quality of life.

27 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

Plasma proteins offer clues to biological aging and mortality risk

A new study published in Geromedicine has identified 17 plasma proteins associated with all-cause mortality in older adults and found that several of these proteins also track with measures of biological aging across multiple organ systems.

27 Oct 2026

High-scoring endocrinologists are more likely to prescribe key diabetes drugs

Endocrinologists who scored highest on the American Board of Internal Medicine's Longitudinal Knowledge Assessment (LKA®) were more likely to prescribe a key diabetes drug class following a treatment guidelines update compared to doctors with lower scores.

27 Oct 2026

Mount Sinai wins $4 million NIH grant to improve prediction of postoperative acute kidney injury

Researchers at the Icahn School of Medicine at Mount Sinai have received a five-year National Institutes of Health grant of approximately $4 million to improve prediction and prevention of postoperative acute kidney injury (AKI), a potentially serious complication after surgery.

27 Oct 2026

New medical framework redefines women’s heart health starting at puberty

The American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine released landmark publications that redefine women's heart health, starting at puberty.

27 Oct 2026

Opioid drop drives decline in drug-related heart infection hospitalizations

A new national study found that hospitalizations for serious heart infections associated with drug use are declining after years of increases, driven largely by a decrease in opioid-associated cases.

27 Oct 2026

High intake of saturated fat can promote favorable changes in cardiovascular risk markers

New analyses from the Norwegian randomized controlled trial CARBFUNC show that more than doubling saturated fat intake over a two-year period can promote favorable changes in several cardiovascular risk markers, without increasing apoB, the main suspected risk factor.

27 Oct 2026

Heated tobacco products cause immediate cardiovascular and genetic damage

Just one session of heated tobacco product use results in measurable damage to the blood vessels, according to a study published today (Tuesday) in the European Journal of Preventive Cardiology.

27 Oct 2026

Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy and/or immunotherapy, according to initial results from a clinical trial presented at the 2026 European Society for Medical Oncology (ESMO) Congress.

27 Oct 2026

Hēlo system offers minimally invasive solution for chronic venous thromboembolism

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated.

27 Oct 2026

Millions get GLP-1 drugs through channels insurance records may miss

Researchers analyzed reports from 9,150 US adults and found that current or previous GLP-1/GIP use rose from 8.2% to 12% between March 2024 and October 2025, largely driven by weight-loss indications. They also estimated that approximately one-third of users obtained treatment through nontraditional channels that standard insurance claims may fail to capture.

26 Oct 2026

Medical societies release landmark framework redefining women's heart health

Today, the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine released a landmark publication that redefines heart health in girls and women.

26 Oct 2026

KAIST team develops neural chip to track Alzheimer's drug response

What happens in the brain after an Alzheimer's drug is administered? A joint research team led by KAIST has used a small, implantable neural chip to wirelessly monitor real-time changes in a neurotransmitter involved in memory and learning.

26 Oct 2026

Simple drug adjustment reduces kidney damage during septic shock surgery

A simple adjustment to drugs given during operations for septic shock could prevent thousands of patients suffering kidney damage, according to a major trial.

26 Oct 2026

New report urges unified lifecycle approach to women's heart health

A new approach to women's heart health may offer them a lifetime of opportunities. A trio of scientific papers, published today in the journal Circulation, spells out how fluctuating hormones, mental health and well-being, the heart and the brain are linked and how those connections need to be a routine part of care from a young age.

26 Oct 2026

Additional education protects people with high genetic risk of dementia

A law that required British teenagers to stay in school for an additional year had an unexpected consequence nearly 50 years later: fewer dementia diagnoses.

26 Oct 2026

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

26 Oct 2026

Geriatric chronic kidney disease patients benefit from SGLT2 inhibition

New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2026 October 22–25.

26 Oct 2026

SAFE Structure Designs supports nonprofit providing prosthetic legs to amputees

SAFE Structure Designs, a Las Vegas-based defense engineering and manufacturing company led by President and CEO Johnny Buscema, is supporting 50 Legs as a donor and raising awareness of its work helping children and adults with limb loss access quality prosthetic legs.

24 Oct 2026